How to Buy Connect Biopharma Holdings Stock

Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation.

Connect Biopharma Holdings stock last closed at $2.00, down 0.99% from the previous day, and has increased 69.49% in one year. It has overperformed other stocks in the Biotechnology industry by 1.35 percentage points. Connect Biopharma Holdings stock is currently +292.16% from its 52-week low of $0.51, and -30.07% from its 52-week high of $2.86.

At the moment, there are 55.56M shares of CNTB outstanding. The market capitalization of CNTB is $111.12M. In the past 24 hours, 241,000 CNTB shares were traded.

How to Buy Connect Biopharma Holdings Stock

Not sure how to invest in Connect Biopharma Holdings stock? Here's how.

  1. Figure out where to buy Connect Biopharma Holdings stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Connect Biopharma Holdings stock.
  2. Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Fund your brokerage account: Choose your payment method and add your details.
  4. Research Connect Biopharma Holdings stock: The Connect Biopharma Holdings ticker symbol is CNTB. Is Connect Biopharma Holdings stock a good investment? Should you buy shares of CNTB? How do CNTB's underlying business fundamentals look? Do top analysts think Connect Biopharma Holdings is a good buy? Why has CNTB's stock price moved recently? (Hint: Our stock market research tools can help you decide if CNTB is a good stock to buy).
  5. Place your CNTB purchase: Decide if you will purchase CNTB shares at the current market price or use a limit order to purchase CNTB stock at a specific price.
  6. Monitor your CNTB position: Create a watchlist to get the latest news on your investment in Connect Biopharma Holdings stock.

Step 1: Figure out where to buy Connect Biopharma Holdings stock

You need a brokerage account to access the NASDAQ market and buy CNTB stock.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global financial markets: From Tech to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen the right brokerage, it's time to fill out some personal info so you are able to buy CNTB stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to start your new trading account.
  1. Submit your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've finished signing up on one of the best stock trading apps, you can securely and quickly fund your account:

Check out this video walkthrough for more details depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Connect Biopharma Holdings stock

Once you have identified the best place to buy Connect Biopharma Holdings stock, it's critical to research their stock before you buy, so you truly comprehend the risk as well as the opportunity.

Connect Biopharma Holdings shares data

CNTB Price
$2.00
1w %
-9.91%
1y %
69.49%
5y %
N/A
P/E
N/A
P/B
1.34x
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$111.12M
Next Earnings
N/A
Next Dividend
N/A

Connect Biopharma Holdings Fundamentals

WallStreetZen was created to help part-time investors do better fundamental analysis in less time.

You can view all of the due diligence checks on CNTB's stock page.

Is CNTB stock undervalued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge CNTB's true value.

Using relative valuations methods:

  • CNTB may be undervalued based on its P/B ratio of 1.34x, relative to Biotechnology industry P/B ratio of 4.3x

You can access additional valuation research on CNTB's stock here.

A look at CNTB Cashflows and Balance Sheet

Signs that CNTB is financially healthy:

  • There are more short-term assets than short-term liabilities on the CNTB balance sheet.
  • CNTB has a low debt to equity ratio of 0.12.
  • There are more short-term assets than long-term liabilities on the CNTB balance sheet.

Is Connect Biopharma Holdings stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 2 Wall Street analysts who track CNTB, the consensus analyst rating on CNTB is a Buy

It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are projecting on the Connect Biopharma Holdings stock forecast page.

CNTB Technicals

SMA10
2.12
SMA20
1.76
SMA50
1.24
SMA100
1
SMA200
1.03
MACD
0.26
MACD Signal
0.28
MACD Histogram
-0.02
RSI
59.15
Stochastic %K
48.45
Stochastic %D
48.49
StochRSI %K
20.28
StochRSI %D
17.09

What are CNTB executives and large shareholders up to?

In the last year, executives and large shareholders at CNTB have not bought or sold any shares.

Research more about who owns CNTB stock here.

Does CNTB stock generate passive income?

No, Connect Biopharma Holdings doesn't provide an income stream by paying out dividends.

CNTB Social Trading Data

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Place your CNTB purchase

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally the best for newer investors.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a given dollar amount limit, use a limit order.

Click the Open button and eToro will execute your order.

If you require additional help with buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Monitor your CNTB position

Now that you own some shares in CNTB, you'll want to keep up with your investment.

Make a watchlist to get notified of the latest news about your CNTB stock.

CNTB Feed

How to Buy Stock in Connect Biopharma Holdings

To reiterate, here are the 6 steps for buying Connect Biopharma Holdings stock:

  1. Figure out where to buy Connect Biopharma Holdings stock
  2. Sign up for a brokerage account
  3. Fund your brokerage account
  4. Research Connect Biopharma Holdings stock
  5. Place your CNTB purchase
  6. Monitor your CNTB position

If you require a online brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to monitor your investment in Connect Biopharma Holdings, add CNTB to your watchlist below.

NASDAQ: CNTB
$2.00-0.02 (-0.99%)
Updated Aug 1, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CNTB
$2.00-0.02 (-0.99%)
Updated Aug 1, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Connect Biopharma Holdings share?

As of Aug 1, 2025, it costs $2.00 to buy one share of Connect Biopharma Holdings stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.5 shares of CNTB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Connect Biopharma Holdings stock?

According to 2 Wall Street analysts who monitor Connect Biopharma Holdings, their consensus recommendation is to buy Connect Biopharma Holdings stock.

What is the best way to buy Connect Biopharma Holdings stock?

One way to place an order for Connect Biopharma Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.